{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:21:17Z","timestamp":1792210877846,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"am","delay-in-days":457,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.euf.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T16:25:21Z","timestamp":1678379121000},"page":"727-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pharmacologic and Surgical Retreatment After Office-based Treatments for Benign Prostatic Hyperplasia: A Systematic Review"],"prefix":"10.1016","volume":"9","author":[{"given":"Michael","family":"Baboudjian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Gondran-Tellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fourmarier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9goire","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Peyronnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Misrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pradere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2023.03.004_b0005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.eururo.2014.12.038","article-title":"EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"67","author":"Gratzke","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1464-410X.2004.04906.x","article-title":"A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia","volume":"94","author":"Boyle","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.03.004_b0015","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.euf.2022.06.007","article-title":"Impact of surgery for benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis of erectile function and ejaculatory function","volume":"8","author":"Manfredi","year":"2022","journal-title":"Eur Urol Focus"},{"issue":"Suppl 1","key":"10.1016\/j.euf.2023.03.004_b0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bju.15098","article-title":"Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data","volume":"126","author":"Morton","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.03.004_b0025","series-title":"Lower urinary tract symptoms in men (male LUTS): etiology, patient assessment and predicting outcome from therapy. Male Lower Urinary Tract Symptoms (LUTS), An International Consultation on Male LUTS","author":"Bosch","year":"2013"},{"key":"10.1016\/j.euf.2023.03.004_b0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2013.02.026","article-title":"Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in France: a comprehensive population study","volume":"64","author":"Lukacs","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2021.03.034","article-title":"Prostatic artery embolisation for male lower urinary tract symptoms related to benign prostatic obstruction: curative option or watchful waiting?","volume":"80","author":"Cornu","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0040","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2023.03.004_b0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2023.03.004_b0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2017.08.016","article-title":"Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology","volume":"73","author":"Knoll","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/sim.8013","article-title":"One-sample aggregate data meta-analysis of medians","volume":"38","author":"McGrath","year":"2019","journal-title":"Stat Med"},{"key":"10.1016\/j.euf.2023.03.004_b0060","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.euf.2023.03.004_b0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41391-020-00281-5","article-title":"3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction","volume":"24","author":"Amparore","year":"2021","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euf.2023.03.004_b0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.urology.2020.12.022","article-title":"The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial","volume":"153","author":"Chughtai","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.euf.2023.03.004_b0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/bju.14141","article-title":"3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction","volume":"122","author":"Porpiglia","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.03.004_b0080","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.purol.2020.05.004","article-title":"Treatment of benign prostate hyperplasia using the Rezum\u00ae water vapor therapy system: results at one year","volume":"30","author":"Alegorides","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.purol.2021.03.001","article-title":"Comparison of water vapor thermal therapy and prostate artery embolization for fragile patients with indwelling urinary catheters: preliminary results from a multi-institutional study","volume":"32","author":"Baboudjian","year":"2022","journal-title":"Prog Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0090","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/pros.24201","article-title":"Rez\u016bm for retention\u2014retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia","volume":"81","author":"Bassily","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2023.03.004_b0095","first-page":"159","article-title":"Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rez\u016bm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"9","author":"Darson","year":"2017","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0100","first-page":"207","article-title":"Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia","volume":"8","author":"Dixon","year":"2016","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.urology.2022.02.001","article-title":"Large, multi-center, prospective registry of Rez\u016bm water vapor therapy for benign prostatic hyperplasia","volume":"165","author":"Elterman","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.euf.2023.03.004_b0110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41391-021-00462-w","article-title":"Rez\u016bm water vapor therapy in multimorbid patients with urinary retention and catheter dependency","volume":"25","author":"Eredics","year":"2022","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euf.2023.03.004_b0115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.acuro.2021.11.003","article-title":"Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rez\u016bm\u00ae steam system","volume":"46","author":"Fern\u00e1ndez-Guzm\u00e1n","year":"2022","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.euf.2023.03.004_b0120","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1007\/s00345-020-03548-7","article-title":"Rezum therapy for patients with large prostates (\u2265 80 g): initial clinical experience and postoperative outcomes","volume":"39","author":"Garden","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0125","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/pros.24191","article-title":"Real-world evidence with the Rez\u016bm system: a retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes","volume":"81","author":"Ines","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2023.03.004_b0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/bju.15203","article-title":"Rezum water vapour therapy: promising early outcomes from the first UK series","volume":"126","author":"Johnston","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.03.004_b0135","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/JU.0000000000001778","article-title":"Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"206","author":"McVary","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41391-017-0022-9","article-title":"Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience","volume":"21","author":"Mollengarden","year":"2018","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euf.2023.03.004_b0145","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00345-021-03642-4","article-title":"Water vapor therapy (Rez\u016bm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study","volume":"39","author":"Siena","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.euros.2022.03.006","article-title":"Real-world early outcomes and retreatment rates following water vapour ablative therapy for symptomatic benign prostatic hyperplasia","volume":"39","author":"Whiting","year":"2022","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.euf.2023.03.004_b0155","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1080\/13685538.2021.1901273","article-title":"The role of Rez\u016bm\u2122 team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review","volume":"23","author":"Wong","year":"2020","journal-title":"Aging Male"},{"key":"10.1016\/j.euf.2023.03.004_b0160","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/13645706.2020.1816554","article-title":"The UroLift\u00ae system for lower urinary tract obstruction: patient selection for optimum clinical outcome","volume":"31","author":"Al-Singary","year":"2022","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"10.1016\/j.euf.2023.03.004_b0165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000441850","article-title":"Prostatic urethral lift: a new minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"96","author":"Bozkurt","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2023.03.004_b0170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/bju.12540","article-title":"Multicentre prospective crossover study of the \u2018prostatic urethral lift\u2019 for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"113","author":"Cantwell","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.03.004_b0175","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.acuro.2019.01.007","article-title":"Minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. Our initial experience with Urolift\u00ae under local anaesthesia and sedation","volume":"43","author":"Cayuelas Rubio","year":"2019","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.euf.2023.03.004_b0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.urology.2011.10.021","article-title":"Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"79","author":"Chin","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.euf.2023.03.004_b0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.purol.2021.09.003","article-title":"La pose d\u2019implant UroLift\u00ae sous anesth\u00e9sie locale: \u00e9tude observationnelle r\u00e9trospective monocentrique [Prostatic urethral lift under local anesthesia: single-centre retrospective observational study]","volume":"32","author":"Dupitout","year":"2022","journal-title":"Prog Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0190","first-page":"584","volume":"66","author":"Garrido Abad","year":"2013","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0195","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bju.13714","article-title":"Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study","volume":"119","author":"Gratzke","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.03.004_b0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5534\/wjmh.190015","article-title":"Evaluation of clinical outcomes of prostatic urethral lift for benign prostatic hyperplasia: an Asian population study","volume":"38","author":"Kim","year":"2020","journal-title":"World J Mens Health"},{"key":"10.1016\/j.euf.2023.03.004_b0205","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.eururo.2013.01.008","article-title":"Minimally invasive prostatic urethral lift: surgical technique and multinational experience","volume":"64","author":"McNicholas","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12894-021-00824-5","article-title":"Prostatic urethral lift (UroLift): a real-world analysis of outcomes using hospital episodes statistics","volume":"21","author":"Page","year":"2021","journal-title":"BMC Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0215","first-page":"8802","article-title":"Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study","volume":"24","author":"Roehrborn","year":"2017","journal-title":"Can J Urol"},{"issue":"Suppl 3","key":"10.1016\/j.euf.2023.03.004_b0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bju.13666","article-title":"24-Month durability after crossover to the prostatic urethral lift from randomised, blinded sham","volume":"118","author":"Rukstalis","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2023.03.004_b0225","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41391-018-0118-x","article-title":"Prostatic urethral lift (PUL) for obstructive median lobes: 12 month results of the MedLift study","volume":"22","author":"Rukstalis","year":"2019","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euf.2023.03.004_b0230","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/end.2017.0855","article-title":"Prostatic urethral lift: does size matter?","volume":"32","author":"Shah","year":"2018","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2023.03.004_b0235","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00345-018-2494-1","article-title":"Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years","volume":"37","author":"Sievert","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.purol.2020.01.003","article-title":"Pose d\u2019implants UroLift\u00ae intra-prostatique pour hyperplasie b\u00e9nigne de la prostate : r\u00e9sultats apr\u00e8s 7 ans d\u2019exp\u00e9rience [Prostatic urethral lift using UroLift\u00ae system for benign prostatic hyperplasia: results after 7 years of experience]","volume":"30","author":"Userovici","year":"2020","journal-title":"Prog Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0245","first-page":"10824","article-title":"Prostatic urethral lift (UroLift) versus convective water vapor ablation (Rezum) for minimally invasive treatment of BPH: a comparison of improvements and durability in 3-year clinical outcomes","volume":"28","author":"Elterman","year":"2021","journal-title":"Can J Urol"},{"key":"10.1016\/j.euf.2023.03.004_b0250","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s11255-021-02899-3","article-title":"Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic benign prostatic hyperplasia: a real-life study","volume":"53","author":"Baboudjian","year":"2021","journal-title":"Int Urol Nephrol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456923000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456923000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:55:04Z","timestamp":1762498504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456923000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2405456923000664"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2023.03.004","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic and Surgical Retreatment After Office-based Treatments for Benign Prostatic Hyperplasia: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}